Browse By: Country ι Category ι Tag
Home  »  Non Small Cell Lung Cancer

Non Small Cell Lung Cancer Market Research Reports

More

United States Non Small Cell Lung Cancer Therapeutics Industry 2016 Market Research Report
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Non Small Cell Lung Cancer Therapeutics market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact info
Published Date: Jun 2016
Published By: QYResearch

Price: $3800
Global Non Small Cell Lung Cancer Therapeutics Consumption 2016 Market Research Report
First, the report provides a basic overview of the Non Small Cell Lung Cancer Therapeutics industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures. Secondly, the report states the global Non Small Cell Lung Cancer Therapeutics market size (volume and value), and the segment markets by regions, types, applications and companies are also discussed. Third, the Non Small Cell Lung Cancer Therapeutics market analysis is provided for major regions including USA, Europe, China and Japan, and other regions can be added. For each region, market size and end users are analyzed as well as segment markets by types, applications and companies. Then, the report focu
Published Date: Jun 2016
Published By: QYResearch

Price: $4000
Non Small Cell Lung Cancer Therapeutics Market: (By Drug Class: Angiogenesis Inhibitor, EGFR Inhibitor, Kinase Inhibitor, Microtubule Stabilizer, Folate Antimetabolites, and PD-1/PD-L1 Inhibitor): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023
This report on the non-small cell lung cancer (NSCLC) Therapeutics market studies the current and future prospects of the global market. Non-small cell lung cancer is a type of lung cancer which accounted 85-90% of all lung cancers. There are three major subtypes of NSCLC namely squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. 
Published Date: Nov 2015
Published By: Transparency

Price: $5795
Gemzar (Non Small Cell Lung Cancer) Analysis and Forecasts to 2015
GlobalDatas pharmaceuticals report, Gemzar (Non Small Cell Lung Cancer) - Analysis and Forecasts to 2015 provides Gemzar sales forecasts for the US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002- 2015). The report also includes information on Non Small Cell Lung Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData\'s team of industry expert
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Tarceva (Non Small Cell Lung Cancer) Analysis and Forecasts to 2015
GlobalDatas pharmaceuticals report, Tarceva (Non Small Cell Lung Cancer) - Analysis and Forecasts to 2020 provides Tarceva sales forecasts for the US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2004-2020). The report also includes information on Non Small Cell Lung Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData\'s team of industry exper
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Vargatef (Non Small Cell Lung Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Vargatef (Non Small Cell Lung Cancer) - Analysis and Forecasts to 2020 provides Vargatef sales forecasts for the US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2015-2020). The report also includes information on Non Small Cell Lung Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData\'s team of industry exp
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Cisplatin (Non Small Cell Lung Cancer) Analysis and forecasts to 2020
GlobalDatas pharmaceuticals report, Cisplatin (Non Small Cell Lung Cancer) - Analysis and Estimates from 2002 to 2020 provides cisplatin sales estimates for the US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Non Small Cell Lung Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData\'s team of
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Abraxane (Non Small Cell Lung Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Abraxane (Non Small Cell Lung Cancer) - Analysis and Forecasts to 2020 provides abraxane sales forecasts for the US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2013-2020). The report also includes information on Non Small Cell Lung Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData\'s team of industry exp
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
ARQ 197 (Non Small Cell Lung Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, ARQ 197 (Non Small Cell Lung Cancer) - Analysis and Forecasts to 2020 provides ARQ 197 sales forecasts for the US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2015-2020). The report also includes information on Non Small Cell Lung Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData\'s team of industry exper
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Opaxio (Non Small Cell Lung Cancer) Analysis and Forecasts to 2020
    GlobalDatas pharmaceuticals report, Opaxio (Non Small Cell Lung Cancer) - Analysis and Forecasts to 2020 provides Opaxio sales forecasts for the US. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2015-2020). The report also includes information on Non Small Cell Lung Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData\'s team of industry experts.
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Etoposide (Non Small Cell Lung Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Etoposide (Non Small Cell Lung Cancer)- Analysis and Forecasts to 2020 provides Etoposide sales forecasts for the US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Non Small Cell Lung Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData\'s team of industry ex
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Talactoferrin Alfa (Non Small Cell Lung Cancer) Analysis and Forecasts to 2020
    GlobalDatas pharmaceuticals report, Talactoferrin Alfa (Non Small Cell Lung Cancer)- Analysis and Forecasts to 2020 provides Talactoferrin Alfa sales forecasts for the US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Non Small Cell Lung Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalDa
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Alimta (Non Small Cell Lung Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Alimta (Non Small Cell Lung Cancer)- Analysis and Forecasts to 2020 provides Alimta sales forecasts for the US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2004-2020). The report also includes information on Non Small Cell Lung Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData\'s team of industry experts.
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Stimuvax (Non Small Cell Lung Cancer) Analysis and Forecasts to 2020
    GlobalDatas pharmaceuticals report, Stimuvax (Non Small Cell Lung Cancer)- Analysis and Forecasts to 2020 provides Stimuvax sales forecasts for the US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2012-2020). The report also includes information on Non Small Cell Lung Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData\'s team of in
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Taxol (Non Small Cell Lung Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Taxol (Non Small Cell Lung Cancer)- Analysis and Forecasts to 2020 provides Taxol sales forecasts for the US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2017). The report also includes information on Non Small Cell Lung Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData\'s team of industry experts.
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Afatinib (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Afatinib (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020 provides Afatinib sales forecasts for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2013-2020). The report also includes information on Non Small Cell Lung Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData\'s team of industry experts.
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Taxotere (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020
  GlobalDatas pharmaceuticals report, Taxotere (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020 provides Taxotere\'s sales forecasts for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Non Small Cell Lung Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData\'s team of industr
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Avastin (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Avastin (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020 provides Avastin sales Forecasts for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2006-2020). The report also includes information on Non-Small Cellular Lung Cancer. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData\'s team of industry experts.  
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Crizotinib (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Crizotinib (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020 provides Crizotinib sales forecasts for US. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2013-2020). The report also includes information on Non-Small Cell Lung Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData\'s team of industry experts.   Note:
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Iressa (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020
    GlobalDatas pharmaceuticals report, Iressa (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020 provides Crizotinib salesforecasts for US. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Non-Small Cell Lung Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData\'s team of industry experts.  
Published Date: Oct 2011
Published By: GlobalData

Price: $2000

Back To Top